Ac. Jones et al., FETAL PERIPHERAL-BLOOD MONONUCLEAR CELL PROLIFERATIVE RESPONSES TO MITOGENIC AND ALLERGENIC STIMULI DURING GESTATION, Pediatric allergy and immunology, 7(3), 1996, pp. 109-116
Blood samples were obtained from fetuses and premature babies (n=51) (
15-34 weeks gestation) to determine at what stage the fetal immune sys
tem was able to produce a positive proliferative response to common al
lergens. Peripheral blood mononuclear cells (PBMC) were stimulated wit
h the mitogen, phytohaemagglutinin (PHA), and the allergens, house dus
t mite, cat fur, birch tree pollen, beta-lactoglobulin, ovalbumin and
bee venom (mellitin). Results were expressed as ratios of stimulated t
o unstimulated H-3 thymidine incorporation, and as percent positive re
sponders. There was an increase in proliferation ratio which correlate
d with increasing gestational age for PHA (p<0.0001), cat fur (p=0.042
), birch pollen (p=0.022) and beta-lactoglobulin (p=0.006). The point
in gestation when cells from some individuals began responding to the
allergens with a ratio of 2.0 was at approximately 22 weeks. PBMC prol
iferative response ratios were higher from samples from babies > 22 we
eks gestation compared to < 22 weeks for the mitogen and all allergens
, except mellitin. There was also a greater proportion of positive res
ponders from samples > 22 weeks compared to < 22 weeks for the mitogen
and all allergens, except mellitin. Maternal exposure to birch pollen
, which has a discrete season, was assessed to determine whether expos
ure had occurred at 22 weeks gestation or beyond. Results showed a hig
her proliferative response in infant cells stimulated with birch polle
n (p=0.005) and higher proportion of positive responders (p=0.01) in t
he group of babies whose mothers had been exposed to birch pollen beyo
nd 22 weeks, compared to those whose mothers had not been so exposed.
These results suggest that in utero fetal exposure to an allergen from
around 22 weeks gestation may result in primary sensitisation to that
allergen, leading to positive proliferative responses, at birth.